On the strength of this evidence, we speculated that TYROBP is likely to be an oncogene engaged in immune regulation and is a new key gene for ccRCC diagnosis and immunotherapy targeting. The gene discussed is TYROBP; the disease is nonpapillary renal cell carcinoma.